ESR1 and metastatic neoplasm: The anatomopathological analysis confirmed ganglionar metastatic disease, compatible with breast origin with positive estrogen receptor (ER) and progesterone receptor (PR) and negative human epidermal growth factor receptor 2 (HER2).